Meta-analysis of trials of recombinant human bone morphogenetic protein-2: What should spine surgeons and their patients do with this information?

Annals of Internal Medicine

Volumn 158, Issue 12, 2013, Pages 912-913

  Resnick, Daniel ^a,c   Bozic, Kevin J ^b,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of Wisconsin Health   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

BONE GRAFT; CLINICAL DECISION MAKING; DRUG EFFICACY; EDITORIAL; GRAFT FAILURE; HUMAN; MEDICAL INFORMATION; META ANALYSIS (TOPIC); NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; RETROGRADE EJACULATION; SPINE FUSION;

BONE MORPHOGENETIC PROTEIN 2; CONFLICT OF INTEREST; DRUG INDUSTRY; HUMANS; INTERVERTEBRAL DISC DEGENERATION; PUBLICATION BIAS; RECOMBINANT PROTEINS; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84879156957     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-158-12-201306180-00010     Document Type: Editorial

References (9)

1. Weinstein JN, Lurie JD, Tosteson TD, Zhao W, Blood EA, Tosteson AN, et al. Surgical compared with nonoperative treatment for lumbar degenerative spondylolisthesis. four-year results in the Spine Patient Outcomes Research Trial (SPORT) randomized and observational cohorts. J Bone Joint Surg Am. 2009; 91:1295-304. [PMID: 19487505]
2. Bridwell KH, Glassman S, Horton W, Shaffrey C, Schwab F, Zebala LP, et al. Does treatment (nonoperative and operative) improve the two-year quality of life in patients with adult symptomatic lumbar scoliosis: a prospective multicenter evidence-based medicine study. Spine (Phila Pa 1976). 2009;34:2171-8. [PMID: 19752703]
3. Glassman SD, Carreon LY, Shaffrey CI, Polly DW, Ondra SL, Berven SH, et al. The costs and benefits of nonoperative management for adult scoliosis. Spine (Phila Pa 1976). 2010;35:578-82. [PMID: 20118843]
4. Resnick DK, Choudhri TF, Dailey AT, Groff MW, Khoo L, Matz PG, et al; American Association of Neurological Surgeons/Congress of Neurological Surgeons. Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 8: lumbar fusion for disc herniation and radiculopathy. J Neurosurg Spine. 2005;2:673-8. [PMID: 16028736]
5. Boden SD. Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine (Phila Pa 1976). 2002;27:S26-31. [PMID: 12205416]
6. Simmonds MC, Brown JV, Heirs MK, Higgins JP, Mannion RJ, Rodgers MA, et al. Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion. A meta-analysis of individual-participant data. Ann Intern Med. 2013;158:877-89.
7. Fu R, Selph S, McDonagh M, Peterson K, Tiwari A, Chou R, et al. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion. A systematic review and meta-analysis. Ann Intern Med. 2013;158: 890-902.
8. Garber AM. Cost-effectiveness and evidence evaluation as criteria for coverage policy. Health Aff (Millwood). 2004;Suppl Web Exclusives:W4-284-96. [PMID: 15451997]
9. Emanuel EJ, Fuchs VR, Garber AM. Essential elements of a technology and outcomes assessment initiative. JAMA. 2007;298:1323-5. [PMID: 17878424]